Sun Yat-sen Memorial Hospital Of Sun Yat-sen University
Clinical trials sponsored by Sun Yat-sen Memorial Hospital Of Sun Yat-sen University, explained in plain language.
-
Could one drug match two for ovarian cancer? trial tests gentler chemo approach
Disease control Not yet recruitingThis study is testing whether paclitaxel chemotherapy alone works as well as the standard paclitaxel-carboplatin combination for advanced ovarian cancer patients with high levels of a specific gene called PARK2. Researchers want to see if using just one drug can reduce side effec…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Heart drug could boost bladder cancer fight
Disease control Not yet recruitingThis early-stage study is testing whether adding a common blood pressure medication (propranolol) to standard immunotherapy and chemotherapy can make treatment more effective for bladder cancer that has spread to lymph nodes. The goal is to shrink tumors better before patients un…
Phase: PHASE1 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Radioactive patch trial aims to stop scar regrowth
Disease control Not yet recruitingThis study is observing if cutting out keloid scars and then applying a special radioactive patch (called 32P) is an effective way to treat them and prevent them from coming back. Researchers will follow 401 people for two years after their treatment to see how often the scars re…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
AI vs. eye: the battle to pick the perfect embryo
Disease control Not yet recruitingThis study aims to see if a new AI-powered test can help doctors choose the best embryo for IVF, leading to more successful pregnancies. It will compare the new method, which analyzes DNA from the fluid around the embryo, against the standard method of looking at the embryo's sha…
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Triple-Threat attack on tough ovarian cancer
Disease control Not yet recruitingThis study is testing a new combination of three drugs to see if it can shrink tumors and control a specific, hard-to-treat type of ovarian cancer that has come back or persisted after prior treatment. It will enroll 36 patients to evaluate how well the treatment works and how sa…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope to keep cancer treatment on track: drug aims to fix dangerous platelet drops
Disease control Not yet recruitingThis study is testing a drug called hetrombopag to see if it can safely raise low platelet counts caused by chemotherapy in women with gynecologic cancers. Low platelets can delay or reduce cancer treatment doses. The goal is to help patients complete their planned chemotherapy c…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for tough ovarian cancer when other treatments fail
Disease control Not yet recruitingThis study is testing a drug called sacituzumab for a specific, hard-to-treat type of ovarian cancer (clear cell carcinoma). It is for patients whose cancer has started growing again after treatment with immunotherapy. The goal is to see if this new drug can shrink tumors and con…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for severe strokes: can a common steroid boost recovery?
Disease control Not yet recruitingThis study is testing if adding a steroid medication (methylprednisolone) to the standard emergency procedure to remove a stroke-causing blood clot helps people recover better. It will involve 912 adults who have had a severe stroke with a large area of brain damage. The goal is …
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for tough breast cancer: experimental combo challenges standard treatment
Disease control Not yet recruitingThis study compares two different drug combinations for people with advanced triple-negative breast cancer who haven't had previous treatment. About 150 participants will receive either an experimental combination (sacituzumab govitecan plus toripalimab) or the current standard c…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug combo trial seeks better tolerability for Tough-to-Treat cervical cancer
Disease control Not yet recruitingThis study is testing if using a lower dose of the drug famitinib, when combined with another drug called camrelizumab, can reduce side effects while still controlling cancer growth. It will involve 120 women with cervical cancer that has returned or spread and is no longer curab…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Doctors test artery-blocking trick to make inoperable liver cancer operable
Disease control Not yet recruitingThis study is testing a new two-step surgical approach for a type of advanced bile duct cancer that is normally considered too risky to remove. First, doctors will block the main artery feeding the tumor to encourage new blood vessels to grow. A few weeks later, they will attempt…
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
New hope for High-Risk breast cancer patients: can extra pill stop Cancer's return?
Disease control Not yet recruitingThis study is testing whether adding the drug ribociclib to standard hormone therapy helps prevent breast cancer from coming back in high-risk patients. It's for women whose cancer didn't completely disappear after initial chemotherapy. Researchers will compare the two-drug combi…
Phase: PHASE3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Scientists test new mRNA cancer vaccine in patients who have run out of options
Disease control Not yet recruitingThis early-stage clinical trial is testing a new personalized mRNA vaccine designed to teach the immune system to attack a specific protein found in a patient's tumor cells. The vaccine is given in combination with an existing immunotherapy drug (anti-PD-1) to boost the body's ca…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
AI sees the future of prostate cancer in biopsy slides
Diagnosis Not yet recruitingThis study is testing a new artificial intelligence (AI) tool designed to predict how long hormone therapy will work for a man with prostate cancer before the cancer becomes resistant. The AI analyzes digital images of a patient's initial prostate biopsy sample. Doctors hope that…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Mar 27, 2026 12:39 UTC
-
AI steps in to solve uncertain thyroid cancer tests
Diagnosis Not yet recruitingThis study is testing a new artificial intelligence (AI) tool designed to help doctors better determine if thyroid nodules are cancerous. It works by analyzing both ultrasound pictures and microscope images of cells taken from the nodule. The goal is to provide clearer answers fo…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Mar 27, 2026 12:37 UTC
-
New surgical flap aims to stop debilitating arm swelling in breast cancer patients
Prevention Not yet recruitingThis study is testing whether a new surgical technique can prevent arm swelling (lymphedema) after breast cancer surgery. During standard lymph node removal, surgeons will rotate a small flap of tissue from the chest wall into the armpit to help support fluid drainage. The study …
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Prevention
Last updated Apr 01, 2026 14:41 UTC